GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » Change In Other Working Capital

Meribank Biotech Co (ROCO:4724) Change In Other Working Capital : NT$32.6 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Meribank Biotech Co Change In Other Working Capital?

Meribank Biotech Co's Change In Other Working Capital for the quarter that ended in Dec. 2023 was NT$19.0 Mil. It means Meribank Biotech Co's Other Working Capital increased by NT$19.0 Mil from Jun. 2023 to Dec. 2023 .

Meribank Biotech Co's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was NT$32.6 Mil. It means Meribank Biotech Co's Other Working Capital increased by NT$32.6 Mil from Dec. 2022 to Dec. 2023 .


Meribank Biotech Co Change In Other Working Capital Historical Data

The historical data trend for Meribank Biotech Co's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meribank Biotech Co Change In Other Working Capital Chart

Meribank Biotech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Other Working Capital
Get a 7-Day Free Trial 50.03 21.79 52.85 46.28 32.57

Meribank Biotech Co Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.65 22.96 23.32 13.55 19.02

Meribank Biotech Co Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$32.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Meribank Biotech Co Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Meribank Biotech Co's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Meribank Biotech Co (ROCO:4724) Business Description

Traded in Other Exchanges
N/A
Address
Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493
Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.

Meribank Biotech Co (ROCO:4724) Headlines

No Headlines